School of Medicine


Showing 1-20 of 52 Results

  • Samuel Ricardo Saenz

    Samuel Ricardo Saenz

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Sam Saenz was born in the Bay Area and received his bachelor’s degree in psychology from Stanford University. He completed his medical degree at UC Irvine’s Program in Medical Education for the Latino Community, and he also obtained a Master’s in Public Health from UC Berkeley. After serving as chief psychiatry resident during his psychiatry residency at Stanford, he completed a fellowship in public psychiatry at UC San Francisco. His professional interests include fostering the next generation of diverse mental health providers as well as advancing justice, equity, and inclusion (JEDI) work in academic medicine.

  • Debra Safer

    Debra Safer

    Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

    Current Research and Scholarly InterestsPrimary research interests include the nature and treatment of eating disorders
    (particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery.

  • Manish Saggar

    Manish Saggar

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)

    Current Research and Scholarly InterestsWe are a computational neuropsychiatry lab dedicated to developing computational methods to better understand brain’s overall dynamical organization in healthy and patient populations. We employ algorithms from a wide range of fields, including Applied Mathematics, Econometrics, Machine Learning, Biophysics, and Network Science.

  • Gregory Lee Sahlem

    Gregory Lee Sahlem

    Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)

    BioDr.Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences. He is board-certified in general psychiatry and addictions medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS). He additionally has advanced training in the treatment of mood and sleep disorders. In addition to being an active clinician, Dr.Sahlem is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab.

    Major areas of study for Dr.Sahlem include: The development of rTMS as a focused treatment for addictive disorders; the development of a novel form of ECT theorized to have reduced cognitive side effects, Focal Electrically Administered Seizure Therapy (FEAST), and; the further development of rTMS for the treatment of mood disorders.

  • Khalid Salaheldin, MD

    Khalid Salaheldin, MD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioKhalid Salaheldin, MD, holds the position of Clinical Assistant Professor and serves as an interventional psychiatrist within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His expertise lies in the specialized care of individuals who present with early psychosis.

    At Stanford, Dr. Salaheldin's current responsibilities encompass a range of clinical activities, including evaluating patients with early psychosis at the INSPIRE clinic, providing care in the inpatient psychiatric unit, and delivering interventional psychiatry services. In addition to his clinical work, he is actively engaged in teaching, conducting research, and fostering collaborative learning among his patients and colleagues.

    His treatment philosophy is a recovery oriented and compassionate approach evaluating vital underlying factors alongside pharmacotherapy & neuromodulatory interventions including: sleep, exercise, nutrition, mindfulness, therapy integration, underlying medical issues, substance use, psychosocial history, and importantly patients’ current relationships (including pets of course!). His approach focuses on meeting patients where they are at in their health journey, aligning treatment with their personal goals, and being actively present in their management.

    Dr. Salaheldin’s research interests include early psychosis interventions, underlying medical causes of psychiatric symptoms, neuromodulation, community/global mental health, spirituality and mental health, healthcare worker mental health, novel psychiatric therapeutics, and mental health parity & policy.

    Before joining Stanford, Dr. Salaheldin served as the academic chief resident at Northwell Health, where his focus centered on designing a consult liaison service for patients experiencing a first episode of psychosis. This pioneering initiative aimed to provide compassionate support to patients and their families from the moment they arrived at the emergency room, throughout their inpatient stay, and during their transition to the outpatient setting. He hopes to continue this work on a local and global scale.

    “True compassion means not only feeling another's pain, but also being moved to help relieve it. ” —Daniel Goleman

  • Katherine Sanborn

    Katherine Sanborn

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr Katherine Sanborn specializes in the treatment of psychiatric inpatients. She has practiced Psychiatry for more than 15 years. Dr. Sanborn has a special interests in residency education, psychotherapy training, administration and developmental psychopathology.

  • Mary Sanders, Ph.D.

    Mary Sanders, Ph.D.

    Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    Current Research and Scholarly InterestsDr. Sanders is the Program Director of the Comprehensive Care Unit at Stanford where she teaches and works with inpatients with eating disorders. She has specialized in the treatment of eating disorders for the past 35 years at Stanford. She has written extensively and presented nationally on the subject of the evaluation and treatment of eating disorders and also in the field of child abuse, specifically in the area of Munchausen by proxy.

    Dr. Sanders is also involved with an international outreach project in Ghana called Project Okurase. This project involved an annual medical health outreach in the village. The project is also creating a model village which includes the building of a medical clinic, vocational school, and homes for families that take in orphans. The project is also involved with bringing safe water, building compost toilets, and bringing solar energy to the village.

  • Gisela Sandoval

    Gisela Sandoval

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences

    BioDr. Gisela Sandoval is a physician scientist with dual board certification who specializes in medical-psychiatric illness caring for individuals that suffer from medical conditions at the interface of medicine and psychiatry, which often requires complex chronic care. In addition she treats children with a broad range of psychiatric disorders including neurodevelopmental disorders, ADHD and mood and anxiety disorders in adolescents. She has a thorough and comprehensive way to approach her patients; she considers not only the clinical symptoms but also the impact of the family structure and the functioning of the child at school. Dr. Sandoval has a special interest in establishing standard of care guidelines to address the needs of chronically ill children to promote healthy habits and medical treatment compliance that promote health and decrease the burden of chronic medical and psychiatric illness.
    Dr. Sandoval graduated with honors from the California Institute of Technology where she performed research in brain physiology and evolution. She earned her medical degree from Harvard Medical School where she also completed a Ph.D. specializing in molecular neurobiology and genetics. Dr. Sandoval completed her residency in general psychiatry at the University of Chicago, during which she received the NIMH Outstanding Resident Award. She went on to complete a fellowship in child and adolescent psychiatry at the New York-Presbyterian Hospital Child and Adolescent Psychiatry Residency of Columbia and Cornell Universities. After training she became the Clinical Director of the Warren Wright Adolescent Center at Northwestern University developing a successful clinical program focused on early identification and intervention for adolescents at risk of mental illness before moving to Stanford.
    Dr. Sandoval scientific interests focus on understanding the molecular, neurophysiological and neural circuits that are responsible for healthy brain development and behavior and understanding how these are altered in the developmental neuropsychiatric disorders resulting in pathological behaviors with the expectation that that could lead to new treatments. Furthermore, she is interested in identifying quantifiable metrics of behavior to better diagnosis mental illness by exploring the use of physical activity monitors to help assess the effectiveness of medical therapies.

  • Maureen Satyshur

    Maureen Satyshur

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Satyshur is a licensed clinical psychologist who specializes in Acceptance and Commitment Therapy, Dialectical Behavioral Therapy, as well as interventions for LGBTQ+ individuals.

  • Vidushi Savant

    Vidushi Savant

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry

    BioDr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.

    She is a double board certified in Psychosomatic Medicine and General Psychiatry.

  • Parnika Prashasti Saxena

    Parnika Prashasti Saxena

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.

  • Alan F. Schatzberg

    Alan F. Schatzberg

    Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.

  • Mariana Schmajuk

    Mariana Schmajuk

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences
    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioMariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.

    Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee.

  • Logan Schneider

    Logan Schneider

    Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.

  • Shebani Sethi MD, ABOM

    Shebani Sethi MD, ABOM

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsImproving metabolic and mental health through dietary metabolic therapies, pharmacological optimization, and other lifestyle interventions in those with severe mental illness, such as bipolar disorder, schizophrenia, major depression is a major focus of her research. Clinical and academic interests include management of psychiatric disorders with co-morbid obesity, insulin resistance, metabolic dysfunction and/or eating disorders, particularly binge eating disorder and bulimia nervosa.

  • Nirao Shah

    Nirao Shah

    Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
    On Leave from 03/01/2024 To 04/19/2024

    Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.

  • Ripal Shah

    Ripal Shah

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioRipal Shah, M.D., M.P.H. is a Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences. She specializes clinically in reproductive psychiatry (the Women's Wellness Clinic - pre-conception, pregnancy, postpartum, breastfeeding, fertility, pre-menstrual dysphoric disorder (PMDD), reproductive and sexual health disorders), lifestyle and integrative approaches to health (the Stanford Center for Integrative Medicine - vitamins, supplements, exercise, behavioral modifications, hypnosis), and in physician wellness (the WellConnect program - serving Stanford resident/fellow/faculty physicians). Dr. Shah is regarded as one of the world's experts in PMDD, and one of very few specifically studying PMDD in women of color.

    Her research areas of focus are on women's reproductive psychiatry, integrative approaches to mental health, diversity & inclusion program development, ethnicity-dependent variability in mental health access and treatment response, psychedelics, spirituality, and minority stress. Her lab also studies the role of Eastern religions on mental health in the U.S., and the connection between Hinduism and psychedelics. Outside of consultations, she specializes in psychotherapy for minority populations, particularly those struggling with issues related to identity (religious identification, racial/ethnic minority stress, racial trauma, professional transitions, changes in family structure or relational status, sexual orientation), as well as cognitive-behavioral therapy for ADHD and anxiety disorders. She has received specialized training in working with Black and South Asian populations.

    While in training at Stanford, she served as Chief Resident and led community partnerships and DEI efforts. She consistently ranked #1 in the Stanford residency (and top 1% in the nation) on the annual knowledge-based examination (PRITE). She is a Disaster Mental Health Responder both domestically and internationally, volunteering after wildfires, hurricanes, and earthquakes. She founded and led the Diversity & Inclusion Advisory Council (DIAC) for psychiatry faculty and residents which is now a model organization for programs across the country, built and then graduated from a Diversity & Health Equity track in the residency, and created the first known Diversity & Health Equity Grand Rounds series. She served as Chair of the Chief Residents’ Council, representing over a thousand physicians to the Stanford Health Care leadership. Before her time at Stanford, she completed an M.P.H. at Harvard University in Health Care Management and Policy, an M.D. from the Mount Sinai School of Medicine in New York with tuition merit scholarship, and a B.S. from Duke University in Economics and Biochemistry.

    She is board certified in Adult Psychiatry, Addiction Medicine, and Obesity Medicine, and board-eligible in Integrative Medicine. She pursued additional training in the fields of Emergency Medicine and Internal Medicine, which has informed her evidence-based approach to integrative medicine. She is credentialed as one of very few physicians in the country able to bill for TMS (transcranial magnetic stimulation), ECT (electroconvulsive therapy), hypnosis, and ketamine infusions. She completed a Certificate in Psychedelic-Assisted Therapies and Research, with training from the Multidisciplinary Association for Psychedelic Studies (MAPS), and also completed MAPS' program MDMA Assisted Therapy Researcher Training. She is on the MDMA Clinical/Monitoring Team for Stanford's Pilot Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive Behavior Therapy for Obsessive Compulsive Disorder: (MDMA+CBT-4-OCD). She advises several companies and research teams on the clinical use of psychedelics in psychiatry, and often consults with media and tech companies as an industry expert. She has been seen in TIME, Forbes, and the Washington Post, and in 2020 was awarded one of the top 25 rising stars in medicine by Medscape.